| Issue Date | Title | Involved Person(s) |
| 14-Feb-2024 | Suicide rates and prescription of antidepressants | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
| 2024 | Suicidality emerging from rapid Venlafaxine discontinuation | Kostic, Milutin; Plöderl, Martin; Hengartner, Michael; Buzejic, Jelena |
| Sep-2023 | Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorder | Plöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P. |
| 5-Aug-2023 | Observational studies of antidepressant use and suicide risk are selectively published in psychiatric journals | Plöderl, Martin; Amendola, Simone; Hengartner, Michael P. |
| 16-Jun-2023 | The serotonin hypothesis of depression : both long discarded and still supported? | Moncrieff, Joanna; Cooper, Ruth E.; Stockmann, Tom; Amendola, Simone; Hengartner, Michael P., et al |
| 9-Feb-2023 | No clear evidence of reduced brain serotonin release capacity in patients with depression | Hengartner, Michael P.; Plöderl, Martin |
| 2022 | Increased suicide risk among younger women in winter during full moon in northern Europe : an artifact or a novel finding? | Plöderl, Martin; Westerlund, Joakim; Hökby, Sebastian; Hadlaczky, Gergö; Hengartner, Michael Pascal |
| 2022 | Suizidpräventive Effekte von Ketamin und Esketamin | Plöderl, Martin; Hengartner, Michael P.; Volkmann, Constantin |
| 17-Dec-2021 | Effect of the FDA black box suicidality warnings for antidepressants on suicide rates in the USA : signal or noise? | Plöderl, Martin; Hengartner, Michael Pascal |
| 8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
| 2021 | Suicidality and other severe psychiatric events with duloxetine : re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgia | Hengartner, Michael Pascal; Plöderl, Martin |
| 2021 | Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression | Hengartner, Michael Pascal; Plöderl, Martin |
| 2021 | Prophylactic effects or withdrawal reactions? : an analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA | Hengartner, Michael Pascal; Plöderl, Martin |
| 2021 | Suicide risk with selective serotonin reuptake inhibitors and other new-generation antidepressants in adults: a systematic review and meta-analysis of observational studies | Hengartner, Michael Pascal; Amendola, Simone; Kaminski, Jakob A.; Kindler, Simone; Bschor, Tom, et al |
| 25-Nov-2020 | Did the introduction and increased prescribing of antidepressants lead to changes in long-term trends of suicide rates? | Amendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal |
